By I. Edwards HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.The deal could be worth up to $2.2 billion for Septerna. This includes more than …
Read More »
Noninvasive diagnostic test measures two proteins, pTau217 and β-amyloid 1-42, found in human plasma
Read More »
Association with Alzheimer disease seen in cross-sectional and longitudinal models
Read More »
No cases of endometrial, ovarian, vaginal, or vulvar cancer were seen
Read More »
High mortality, particularly in men, and major complications persist
Read More »
The phospholipid C38:4 phosphatidylethanolamine may partially mediate air pollution-related bone damage
Read More »
Glasgow Hearing Aid Benefit Profile was significantly higher for hearing aids fitted by audiologists following best practice
Read More »
Risk for MACE lower in adult-onset T1D versus T2D, but mortality higher from diabetic coma or ketoacidosis
Read More »
Higher stroke risk seen overall, and higher risk of acute myocardial infarction seen in those with Down syndrome under 40 years of age
Read More »
Findings from a proof-of-concept study using patients' smartphone mobility data
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.